Trailhead Biosystems

Trailhead Biosystems

Biotechnology Research

Cleveland, OH 3,874 followers

Morally obligated to deliver cells you can trust.

About us

Trailhead Biosystems merges developmental biology and cell therapeutics with cutting edge hardware, and computerized experimental design and analysis to perform process-specific parameter optimization for customers seeking to develop cell therapies. Implementing Quality by Design (QbD) principles, cell culture optimization is done by utilizing Design of Experiment (DoE) theory combined with Multivariate Data Analysis (MVDA). This allows Trailhead to generate mathematical models of the biological system, understand the effector-response relationship in cell culture, and provide a systems biology analysis of the differentiation space. DoE-based experimental design and robotic execution greatly reduce the number of experiments and time needed for optimizing a large number of variables simultaneously. You will see that Trailhead Biosystems is novel from its ability to: Have computer-based experimental designs executed for advanced cell culture Gain knowledge into how cell culture affects gene expression in cells Mathematically model the effector/response space so virtual experiments can be performed and enable exploration of cell biology to predict how additives will create desirable cell culture fates Address optimization challenges for cell purity and potency Understand the variance in cell manufacturing methods

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cleveland, OH
Type
Privately Held
Founded
2015
Specialties
Cell Culture Optimization, Mathematical Modeling, Stem Cell Differentiation, Systems Developmental Biology, Big Data 2 Knowledge (BD2K), Morphogens and Growth Factors, Human Development, Design-of-Experiments, Quality-by-Design, Regenerative Medicine, Cell Therapy, and Disease Modeling

Locations

Employees at Trailhead Biosystems

Updates

Similar pages

Browse jobs

Funding

Trailhead Biosystems 4 total rounds

Last Round

Series unknown

US$ 3.0M

See more info on crunchbase